Oxigen Sol (Oxygen)

Oxygen, the active ingredient in Oxigen Sol, is a medical gas presented as a inhalation gas for respiratory support use. It assists patients with compromised breathing by providing supplemental oxygen. GNH USA supplies Oxigen Sol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

GNH USA supplies Oxigen Sol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Oxigen Sol is used in respiratory care pathways for conditions that impair oxygenation.

- Acute hypoxemia: improves oxygen saturation and supports tissue oxygen delivery. - Chronic obstructive pulmonary disease (COPD): helps maintain adequate oxygen levels during exacerbations. - Post‑operative recovery: provides supplemental oxygen to aid healing and reduce hypoxic stress. - High‑altitude exposure: prevents hypoxia‑related symptoms in susceptible individuals. - Carbon dioxide reduction therapy (ECMO or ECCO₂ R R ): enhances oxygen transfer in extracorporeal circuits for critical care patients.

Oxigen Sol may cause adverse reactions related to the delivery of a gas to the respiratory tract.

Common Side Effects: - Dry mouth or throat irritation. - Cough or mild bronchospasm. - Nasal congestion or discomfort from nasal cannula. - Headache due to changes in CO₂ retention. - Mild dizziness or light‑headedness.

Serious or Rare Side Effects: - Oxygen toxicity leading to pulmonary inflammation. - Seizures from high‑concentration exposure. - Vision changes (retinopathy) with prolonged high‑dose therapy. - Barotrauma from excessive airway pressure. - Severe bronchospasm or anaphylactoid reaction. - Hypercapnia in patients with impaired CO₂ clearance.

When using Oxigen Sol, follow safety and handling guidelines to protect patients and staff.

- Patient assessment: verify indication and required oxygen flow rate before administration. - Monitoring: continuously observe oxygen saturation and respiratory status during therapy. - Equipment check: ensure delivery devices (cannula, mask, ventilator) are clean and functioning. - Contraindications: avoid use in patients with untreated pneumothorax or severe hypercapnic respiratory failure unless closely monitored. - Fire safety: keep away from open flames and sources of ignition. - Store at ambient temperature: keep container in original packaging, protect from direct sunlight and extreme temperatures.

Oxigen Sol can interact with other therapies that affect respiratory function or oxygen metabolism.

Major Interactions (Avoid): - Nitrogen dioxide exposure: combined use may increase risk of lung irritation. - High‑concentration anesthetic gases: may potentiate respiratory depression.

Moderate Interactions (Monitor Closely): - Sedatives or opioids: monitor for additive respiratory depression. - Bronchodilators: assess response as oxygen may alter drug efficacy. - Carbon‑monoxide poisoning treatment: adjust oxygen flow to avoid rebound hypoxia. - Hyperbaric oxygen therapy: coordinate dosing to prevent oxygen toxicity. - Inhaled corticosteroids: watch for increased local irritation.